S&P 500   4,471.37 (+0.75%)
DOW   35,294.76 (+1.09%)
QQQ   368.94 (+0.63%)
AAPL   144.84 (+0.75%)
MSFT   304.21 (+0.48%)
FB   324.76 (-1.15%)
GOOGL   2,827.36 (+0.15%)
TSLA   843.03 (+3.02%)
AMZN   3,409.02 (+3.31%)
NVDA   218.62 (+0.53%)
BABA   168.00 (+0.73%)
NIO   37.71 (+3.94%)
CGC   13.35 (-2.55%)
GE   104.41 (+1.63%)
MU   67.68 (-0.18%)
AMD   112.12 (+0.12%)
T   25.70 (+0.31%)
F   15.70 (+1.62%)
ACB   7.03 (-3.17%)
DIS   176.46 (+1.18%)
PFE   41.49 (-0.43%)
BA   217.04 (-0.18%)
AMC   40.74 (+1.67%)
S&P 500   4,471.37 (+0.75%)
DOW   35,294.76 (+1.09%)
QQQ   368.94 (+0.63%)
AAPL   144.84 (+0.75%)
MSFT   304.21 (+0.48%)
FB   324.76 (-1.15%)
GOOGL   2,827.36 (+0.15%)
TSLA   843.03 (+3.02%)
AMZN   3,409.02 (+3.31%)
NVDA   218.62 (+0.53%)
BABA   168.00 (+0.73%)
NIO   37.71 (+3.94%)
CGC   13.35 (-2.55%)
GE   104.41 (+1.63%)
MU   67.68 (-0.18%)
AMD   112.12 (+0.12%)
T   25.70 (+0.31%)
F   15.70 (+1.62%)
ACB   7.03 (-3.17%)
DIS   176.46 (+1.18%)
PFE   41.49 (-0.43%)
BA   217.04 (-0.18%)
AMC   40.74 (+1.67%)
S&P 500   4,471.37 (+0.75%)
DOW   35,294.76 (+1.09%)
QQQ   368.94 (+0.63%)
AAPL   144.84 (+0.75%)
MSFT   304.21 (+0.48%)
FB   324.76 (-1.15%)
GOOGL   2,827.36 (+0.15%)
TSLA   843.03 (+3.02%)
AMZN   3,409.02 (+3.31%)
NVDA   218.62 (+0.53%)
BABA   168.00 (+0.73%)
NIO   37.71 (+3.94%)
CGC   13.35 (-2.55%)
GE   104.41 (+1.63%)
MU   67.68 (-0.18%)
AMD   112.12 (+0.12%)
T   25.70 (+0.31%)
F   15.70 (+1.62%)
ACB   7.03 (-3.17%)
DIS   176.46 (+1.18%)
PFE   41.49 (-0.43%)
BA   217.04 (-0.18%)
AMC   40.74 (+1.67%)
S&P 500   4,471.37 (+0.75%)
DOW   35,294.76 (+1.09%)
QQQ   368.94 (+0.63%)
AAPL   144.84 (+0.75%)
MSFT   304.21 (+0.48%)
FB   324.76 (-1.15%)
GOOGL   2,827.36 (+0.15%)
TSLA   843.03 (+3.02%)
AMZN   3,409.02 (+3.31%)
NVDA   218.62 (+0.53%)
BABA   168.00 (+0.73%)
NIO   37.71 (+3.94%)
CGC   13.35 (-2.55%)
GE   104.41 (+1.63%)
MU   67.68 (-0.18%)
AMD   112.12 (+0.12%)
T   25.70 (+0.31%)
F   15.70 (+1.62%)
ACB   7.03 (-3.17%)
DIS   176.46 (+1.18%)
PFE   41.49 (-0.43%)
BA   217.04 (-0.18%)
AMC   40.74 (+1.67%)
CVE:ADK

DIAGNOS Stock Forecast, Price & News

C$0.51
0.00 (0.00 %)
(As of 10/15/2021 02:56 PM ET)
Add
Compare
Today's Range
C$0.48
C$0.51
50-Day Range
C$0.43
C$0.55
52-Week Range
C$0.42
C$0.77
Volume50,520 shs
Average Volume112,082 shs
Market CapitalizationC$34.84 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ADK News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.


About DIAGNOS

DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$295,344.00
Cash Flow
C$0.02 per share
Book Value
C$0.02 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$34.84 million
Next Earnings Date
11/24/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.19 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












DIAGNOS (CVE:ADK) Frequently Asked Questions

What stocks does MarketBeat like better than DIAGNOS?

Wall Street analysts have given DIAGNOS a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DIAGNOS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is DIAGNOS's next earnings date?

DIAGNOS is scheduled to release its next quarterly earnings announcement on Wednesday, November 24th 2021.
View our earnings forecast for DIAGNOS
.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (CVE:ADK) issued its earnings results on Tuesday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.08 million for the quarter.
View DIAGNOS's earnings history
.

How has DIAGNOS's stock price been impacted by Coronavirus?

DIAGNOS's stock was trading at C$0.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ADK shares have increased by 131.8% and is now trading at C$0.51.
View which stocks have been most impacted by COVID-19
.

Who are DIAGNOS's key executives?

DIAGNOS's management team includes the following people:
  • Mr. Andre Larente, CEO, Pres & Exec. Director
  • Mr. Marc-André Massue, VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles, VP of Sales

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?

DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?

Shares of ADK and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of ADK stock can currently be purchased for approximately C$0.51.

How much money does DIAGNOS make?

DIAGNOS has a market capitalization of C$34.84 million and generates C$295,344.00 in revenue each year.

What is DIAGNOS's official website?

The official website for DIAGNOS is www.diagnos.ca.

Where are DIAGNOS's headquarters?

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The company can be reached via phone at +1-450-6788882.


This page was last updated on 10/15/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.